pharma · Anorectal Disorder · Localized Primary Osteoarthritis of Both Hips (Diagnosis)
Chia Tai Tianqing
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Chia Tai Tianqing clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Lianyungang, CN
- Employees
- 366
- Programs
- 11
- Drugs
- 15
- Patents
- 0
Chia Tai Tianqing projects
4 ClinicalTrials.gov programs sponsored by Chia Tai Tianqing.
Chia Tai Tianqing has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Dexamethasone
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Localized Primary Osteoarthritis of Both Hips (Diagnosis)
1 trial -
Hepatitis B vaccine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Hepatitis B Vaccination, HIV
1 trial -
Topiramate
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Alcohol Dependence
1 trial -
risperidone
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Neuroleptic-Induced Tardive Dyskinesia
1 trial
Frequently asked questions
How many clinical projects does Chia Tai Tianqing have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.